These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19323956)

  • 1. The contribution of hematopoietic stem cells to beta-cell replacement.
    Sordi V; Piemonti L
    Curr Diab Rep; 2009 Apr; 9(2):119-24. PubMed ID: 19323956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of marginal mass required for successful islet transplantation in a diabetic rat model using adipose tissue-derived mesenchymal stromal cells.
    Navaei-Nigjeh M; Moloudizargari M; Baeeri M; Gholami M; Lotfibakhshaiesh N; Soleimani M; Vasheghani-Farahani E; Ai J; Abdollahi M
    Cytotherapy; 2018 Sep; 20(9):1124-1142. PubMed ID: 30068495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological reversal of autoimmune diabetes without hematopoietic replacement of beta cells.
    Suri A; Calderon B; Esparza TJ; Frederick K; Bittner P; Unanue ER
    Science; 2006 Mar; 311(5768):1778-80. PubMed ID: 16556846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to make insulin-producing pancreatic β cells for diabetes treatment.
    Lu J; Xia Q; Zhou Q
    Sci China Life Sci; 2017 Mar; 60(3):239-248. PubMed ID: 27796637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct comparison of the abilities of bone marrow mesenchymal versus hematopoietic stem cells to reverse hyperglycemia in diabetic NOD.SCID mice.
    Arany EJ; Waseem M; Strutt BJ; Chamson-Reig A; Bernardo A; Eng E; Hill DJ
    Islets; 2018; 10(4):137-150. PubMed ID: 30110202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-producing cells derived from stem cells: recent progress and future directions.
    Santana A; Enseñat-Waser R; Arribas MI; Reig JA; Roche E
    J Cell Mol Med; 2006; 10(4):866-83. PubMed ID: 17125591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From Beta cell replacement to beta cell regeneration: implications for antidiabetic therapy.
    Liu C; Wu H
    J Diabetes Sci Technol; 2014 Nov; 8(6):1221-6. PubMed ID: 25355714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regeneration of pancreatic beta cells.
    Jun HS
    Front Biosci; 2008 May; 13():6170-82. PubMed ID: 18508651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell applications in diabetes.
    Noguchi H
    J Stem Cells; 2012; 7(4):229-44. PubMed ID: 24196798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes mellitus: a potential target for stem cell therapy.
    Burns CJ; Persaud SJ; Jones PM
    Curr Stem Cell Res Ther; 2006 May; 1(2):255-66. PubMed ID: 18220871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The state of the art of islet transplantation and cell therapy in type 1 diabetes.
    Pellegrini S; Cantarelli E; Sordi V; Nano R; Piemonti L
    Acta Diabetol; 2016 Oct; 53(5):683-91. PubMed ID: 26923700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.
    Fändrich F; Ungefroren H
    Adv Exp Med Biol; 2010; 654():641-65. PubMed ID: 20217518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro differentiation potential of human haematopoietic CD34(+) cells towards pancreatic β-cells.
    Sunitha MM; Srikanth L; Santhosh Kumar P; Chandrasekhar C; Sarma PV
    Cell Biol Int; 2016 Oct; 40(10):1084-93. PubMed ID: 27514733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cells to pancreatic beta-cells: new sources for diabetes cell therapy.
    Guo T; Hebrok M
    Endocr Rev; 2009 May; 30(3):214-27. PubMed ID: 19389995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reprogramming pancreatic cells to β cells].
    Vieira A; Druelle N; Courtney M; Avolio F; Ben-Othman N; Pfeifer A; Gjernes E; Faurite B; Collombat P
    Med Sci (Paris); 2013; 29(8-9):749-55. PubMed ID: 24005630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BMS 493 Modulates Retinoic Acid-Induced Differentiation During Expansion of Human Hematopoietic Progenitor Cells for Islet Regeneration.
    Elgamal RM; Bell GI; Krause SCT; Hess DA
    Stem Cells Dev; 2018 Aug; 27(15):1062-1075. PubMed ID: 29737242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-cell replacement and regeneration: Strategies of cell-based therapy for type 1 diabetes mellitus.
    Limbert C; Päth G; Jakob F; Seufert J
    Diabetes Res Clin Pract; 2008 Mar; 79(3):389-99. PubMed ID: 17854943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Islet Regeneration: Endogenous and Exogenous Approaches.
    Docherty FM; Sussel L
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33804882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of diabetes in non-obese diabetic mice without spleen cell-derived beta cell regeneration.
    Chong AS; Shen J; Tao J; Yin D; Kuznetsov A; Hara M; Philipson LH
    Science; 2006 Mar; 311(5768):1774-5. PubMed ID: 16556844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regeneration of the pancreas: proliferation and cellular conversion of surviving cells.
    Sever D; Grapin-Botton A
    Curr Opin Genet Dev; 2020 Oct; 64():84-93. PubMed ID: 32721583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.